A randomized clinical trial to stimulate the cholinergic anti-inflammatory pathway in patients with moderate COVID-19-pneumonia using a slow-paced breathing technique | Synapse
October 3, 2022Open Access
A randomized clinical trial to stimulate the cholinergic anti-inflammatory pathway in patients with moderate COVID-19-pneumonia using a slow-paced breathing technique
Key Points
Key points are not available for this paper at this time.
Abstract
https://www.drks.de, identifier DRKS00023971, Universal Trial Number (UTN) U1111-1263-8658.